Evidence map›Paper›PMID 41441061›Full record

ArticleMembranes2025

Pharmaceuticals, Pesticides, and Poly- and Perfluoroalkyl Substances at Surface Water Occurrence Levels-Impact of Compound Specific Physicochemical Properties on Nanofiltration and Reverse Osmosis Processes.

Jelena Šurlan, Claudia F Galinha, Nikola Maravić, Carla Brazinha, Igor Antić, Jelena Živančev, Nataša Đurišić-Mladenović, Zita Šereš, João G Crespo

Abstract read
In one paragraph

Article in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jelena ŠurlanFaculty of Technology Novi Sad, University of Novi Sad, Bul. Cara Lazara 1, 21000 Novi Sad, Serbia.ORCID 0000-0002-1385-5097
Claudia F GalinhaLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, FCT NOVA, Unversidade NOVA de Lisboa, 2829-516 Caparica, Portugal.ORCID 0000-0003-0045-2528
Nikola MaravićFaculty of Technology Novi Sad, University of Novi Sad, Bul. Cara Lazara 1, 21000 Novi Sad, Serbia.ORCID 0000-0002-0643-3662
Carla BrazinhaDepartment of Bioengineering and iBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.ORCID 0000-0002-7784-0265
Igor AntićFaculty of Technology Novi Sad, University of Novi Sad, Bul. Cara Lazara 1, 21000 Novi Sad, Serbia.ORCID 0000-0003-3246-5825
Jelena ŽivančevFaculty of Technology Novi Sad, University of Novi Sad, Bul. Cara Lazara 1, 21000 Novi Sad, Serbia.ORCID 0000-0002-2568-2189
Nataša Đurišić-MladenovićFaculty of Technology Novi Sad, University of Novi Sad, Bul. Cara Lazara 1, 21000 Novi Sad, Serbia.ORCID 0000-0002-5203-6051
Zita ŠerešFaculty of Technology Novi Sad, University of Novi Sad, Bul. Cara Lazara 1, 21000 Novi Sad, Serbia.ORCID 0000-0001-8384-7562
João G CrespoLAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, FCT NOVA, Unversidade NOVA de Lisboa, 2829-516 Caparica, Portugal.ORCID 0000-0001-8714-3781

Funding

European Commission 101059867
6 · The paper itself

Abstract

Pharmaceutically active compounds (PhACs), pesticides, and poly- and perfluoroalkyl substances (PFAS) are increasingly detected in surface waters at trace concentrations, raising concerns for both aquatic systems and, consequently, human health. Conventional solutions are insufficient to achieve complete removal at trace compound concentrations, highlighting the need for advanced separation technologies. This study aims to comprehensively analyze rejection and removal mechanisms of selected PhACs, pesticides, and PFAS present in water solutions at reported environmentally relevant concentrations (300 ng L

Indexed as

nanofiltrationpesticidesPFASpharmaceuticalsreverse osmosiswater treatment

Identifiers

PMID41441061
PMCPMC12734873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.